Skip to content
Sexuality – Lifestyle
Author:
Medera Inc.
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
August 4, 2026
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
June 25, 2026
Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program
June 8, 2026
Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy
April 16, 2026